Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics of Warfarin in Puerto Rican Patients Using a Physiogenomics Approach.

NCT01318057 is registered in ClinicalTrials.gov with University of Puerto Rico as lead sponsor.

NCT NCT01318057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics of Warfarin in Puerto Rican Patients Using a Physiogenomics Approach.
Lead sponsor
University of Puerto Rico
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
July 31, 2014
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, atrial fibrillation, cardiac valvular insufficiency, coagulopathy, deep vein thrombosis